Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression
- 13 May 2005
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 379 (3) , 229-234
- https://doi.org/10.1016/j.neulet.2005.01.008
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Polymorphism at Codon 66 of the Brain-Derived Neurotrophic Factor Gene Is Not Associated with Sporadic Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2004
- Brain‐derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in ItalyAnnals of Neurology, 2004
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionPublished by Elsevier ,2003
- Region-Specific Neurotrophin Imbalances in Alzheimer DiseaseArchives of Neurology, 2000
- BDNF and Full-length and Truncated TrkB Expression in Alzheimer Disease. Implications in Therapeutic StrategiesJournal of Neuropathology and Experimental Neurology, 1999
- Brain-derived neurotrophic factor is reduced in Alzheimer's diseasePublished by Elsevier ,1998
- Amyloid, the presenilins and Alzheimer's diseaseTrends in Neurosciences, 1997
- Heritability for Alzheimer's Disease: The Study of Dementia in Swedish TwinsThe Journals of Gerontology: Series A, 1997
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- “Mini-mental state”Journal of Psychiatric Research, 1975